Phil Gold

Phil Gold is a Canadian physician, scientist, and professor known for his significant contributions to the field of medicine, particularly in cancer research. He is best known for his discovery of the carcinoembryonic antigen (CEA), a tumor marker used in the diagnosis and management of certain types of cancer.

Early Life and Education

Phil Gold was born in Montreal, Quebec, Canada. He completed his undergraduate studies at McGill University, where he earned a Bachelor of Science degree. He continued his education at McGill, obtaining both his Doctor of Medicine (M.D.) and Doctor of Philosophy (Ph.D.) degrees.

Career

Gold began his career at McGill University and its affiliated hospitals. He held various positions, including Professor of Medicine, Professor of Physiology, and Chairman of the Department of Medicine. His research primarily focused on cancer and immunology.

Discovery of Carcinoembryonic Antigen (CEA)

In the 1960s, Phil Gold, along with his colleague Samuel O. Freedman, discovered the carcinoembryonic antigen (CEA). This discovery was groundbreaking as it provided a new method for detecting and monitoring certain types of cancer, particularly colorectal cancer. CEA is now widely used as a tumor marker in clinical practice.

Awards and Honors

Phil Gold has received numerous awards and honors for his contributions to medical science. Some of these include:

• Order of Canada
• National Order of Quebec
• Gairdner Foundation International Award
• Canadian Medical Hall of Fame

Legacy

Phil Gold's work has had a lasting impact on the field of cancer research and clinical practice. His discovery of CEA has improved the diagnosis and management of cancer patients worldwide. He continues to be an influential figure in medical research and education.

See Also

• Carcinoembryonic antigen
• McGill University
• Cancer research
• Order of Canada
• National Order of Quebec